Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs.
Brandt
Kenneth D
KD
Rheumatology Division, Indiana University School of Medicine, 1110 West Michigan Street, Rm. LO 545, Indianapolis, IN 46202-5100, USA. kbrandt@iupui.edu
Mazzuca
Steven A
SA
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D006801:Humans; D007596:Joints / Q000187:drug effects / Q000503:physiopathology; D008297:Male; D015207:Osteoarthritis, Hip / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D020370:Osteoarthritis, Knee / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D010146:Pain / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D018501:Antirheumatic Agents